BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 19248640)

  • 21. Antimicrobial stewardship.
    Rybak MJ
    Pharmacotherapy; 2007 Oct; 27(10 Pt 2):131S-135S. PubMed ID: 17896906
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Use of antibiotics in hospital--to guide or to limit].
    Hautala T; Lumio J
    Duodecim; 2005; 121(15):1683-8. PubMed ID: 16211843
    [No Abstract]   [Full Text] [Related]  

  • 23. Investigation of antimicrobial use and the impact of antimicrobial use guidelines in a small animal veterinary teaching hospital: 1995-2004.
    Weese JS
    J Am Vet Med Assoc; 2006 Feb; 228(4):553-8. PubMed ID: 16478430
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevalence, consequences, and solutions.
    Maki DG; Safdar N; Ebert SC
    Pharmacotherapy; 2007 Oct; 27(10 Pt 2):121S-125S. PubMed ID: 17896904
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Performance of the TREAT decision support system in an environment with a low prevalence of resistant pathogens.
    Kofoed K; Zalounina A; Andersen O; Lisby G; Paul M; Leibovici L; Andreassen S
    J Antimicrob Chemother; 2009 Feb; 63(2):400-4. PubMed ID: 19091808
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Importance of the antimicrobial spectrum and the bacterial resistances in the antibiotic choice for the treatment of pediatric patients with communitary infections].
    Baquero F; González J; Martínez D; Olmo V; Orero A; Prieto J;
    Rev Esp Quimioter; 2009 Mar; 22(1):38-47. PubMed ID: 19308746
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Correlating antibiotic consumption with antimicrobial resistance of uropathogens in a university teaching hospital in Lagos, Nigeria.
    Oduyebo OO; Onwuezobe IA; Olayemi SO; Akintunde AS
    Niger J Clin Pract; 2008 Dec; 11(4):305-8. PubMed ID: 19320399
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Improved antimicrobial interventions have benefits.
    Barenfanger J; Short MA; Groesch AA
    J Clin Microbiol; 2001 Aug; 39(8):2823-8. PubMed ID: 11473998
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antibiotic utilisation surveillance from pharmacoeconomic/pharmacotherapeutic standpoint with control of bacterial resistance.
    Stefan-Mikić S
    Med Pregl; 2008; 61 Suppl 1():7-8. PubMed ID: 19256063
    [No Abstract]   [Full Text] [Related]  

  • 30. Methods of documenting cost savings associated with an antibiotic management program.
    Lacy MK; Eidem LA; Bond JA; Swartz MA
    Pharm Pract Manag Q; 1996 Jul; 16(2):66-70. PubMed ID: 10161615
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Management of severe bacterial infections.
    Esposito S; Leone S; Noviello S
    Expert Rev Anti Infect Ther; 2005 Aug; 3(4):593-600. PubMed ID: 16107198
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Short course antibiotherapies in community-acquired pneumonia].
    Bulbul Y; Ozlu T
    Tuberk Toraks; 2008; 56(3):344-52. PubMed ID: 18932039
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Federal funding for the study of antimicrobial resistance in nosocomial pathogens: no ESKAPE.
    Rice LB
    J Infect Dis; 2008 Apr; 197(8):1079-81. PubMed ID: 18419525
    [No Abstract]   [Full Text] [Related]  

  • 34. Five-year surveillance of antimicrobial use in Chinese Pediatric Intensive Care Units.
    Ding H; Yang Y; Lu Q; Wang Y; Chen Y; Deng L; Wang A; Deng Q; Zhang H; Wang C; Liu L; Xu X; Wang L; Shen X
    J Trop Pediatr; 2008 Aug; 54(4):238-42. PubMed ID: 18222941
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Predicting antibiotic resistance.
    Martínez JL; Baquero F; Andersson DI
    Nat Rev Microbiol; 2007 Dec; 5(12):958-65. PubMed ID: 18007678
    [TBL] [Abstract][Full Text] [Related]  

  • 36. New antimicrobial agents for the treatment of bacterial infections in cancer patients.
    Rolston KV
    Hematol Oncol; 2009 Sep; 27(3):107-14. PubMed ID: 19569253
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Antibiotics in current infections].
    Semaille P
    Rev Med Brux; 2007 Sep; 28(4):396-403. PubMed ID: 17958040
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Appropriateness of antimicrobial therapy measured by repeated prevalence surveys.
    Willemsen I; Groenhuijzen A; Bogaers D; Stuurman A; van Keulen P; Kluytmans J
    Antimicrob Agents Chemother; 2007 Mar; 51(3):864-7. PubMed ID: 17210766
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antimicrobial resistance: a deadly burden no country can afford to ignore.
    Birnbaum D;
    Can Commun Dis Rep; 2003 Sep; 29(18):157-64. PubMed ID: 14524197
    [No Abstract]   [Full Text] [Related]  

  • 40. [Implementation of antimicrobial resistance surveillance and antibiotic consumption in an intensive care burn department].
    Messadi AA; Thabet L; Bousselmi K; Oueslati S; Ben Redjeb S
    Tunis Med; 2008 May; 86(5):486-9. PubMed ID: 19469305
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.